During the projected period in Germany, the market for cervical dysplasia is expected to increase significantly due to the rise in product approvals. For instance, Abbott Laboratories' Alinity m diagnostics assays and systems obtained a CE mark in March 2019. The technique is used to test for HIV-1, hepatitis B and C viruses as well as sexually transmitted diseases such Neisseria gonorrhoeae, Mycoplasma genitalium, Chlamydia trachomatis, Trichomonas vaginalis, and HPV. Therefore, the Cervical Dysplasia Market in Germany is anticipated to rise as a result of an increase in product development by key industry participants.
The following are a few of the leading companies in the cervical dysplasia market F. Hoffmann La-Roche Ltd., QIAGEN N.V., Becton, Dickinson and Company, OncoHealth Corporation, Quest Diagnostics, Inc., Hologic, Inc., Abbott Laboratories, ASKA Pharmaceutical Co., Ltd., Asieris Pharmaceuticals, BetterLife Pharma Inc., and KinoPharma, Inc.
Read More- https://cmi-latestreportorientedblogs.blogspot.com/2022/11/cervical-dysplasia-market-emerging.html
